Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target. IJPRMP 2026, 2 (5), 76-82. https://doi.org/10.61280/4sa10p81.